Nuclera
Nuclera’s mission is to better human health by enabling scientists to easily access the proteins they need for drug discovery research. The Company’s eProtein Discovery™ benchtop System accelerates protein expression and purification optimization in research labs. Applying digital microfluidics alongside in situ protein detection assays and cell-free protein synthesis, eProtein Discovery enables rapid, scalable access to high-quality proteins, supporting both cell-free and cell-based expression methods. The System significantly reduces time and cost of these processes by automating construct screening, protein scale-up, and producing purified proteins in under 48 hours for downstream functional testing. The System accelerates workflows, achieving results in days rather than the months required by traditional cell-based methods. Founded in 2013, Nuclera’s offices are located in Cambridge (UK) and Boston (US).Content by Nuclera
| 5 min read
Cell-free expression systems are transforming membrane protein research by enabling faster, more reliable access to functional proteins for drug discovery applications.
| 2 min read
Collaboration allows researchers to progress rapidly from DNA to purified and characterized protein, to facilitate insights into drug-target interactions
Page 1 of 1 - 2 Total Items
